Glutamine should be reclassified as a conditionally essential amino acid in
the catabolic state because the body's glutamine expenditures exceed synth
esis and low glutamine levels in plasma are associated with poor clinical o
utcome. After severe stress, several amino acids are mobilized from muscle
tissue to supply energy and substrate to the host. Glutamine is one of the
most important amino acids that provide this function. Glutamine acts as th
e preferred respiratory fuel for lymphocytes, hepatocytes and intestinal mu
cosal cells and is metabolized in the gut to citrulline, ammonium and other
amino acids. Low concentrations of glutamine in plasma reflect reduced sto
res in muscle and this reduced availability of glutamine in the catabolic s
tate seems to correlate with increased morbidity and mortality. Adding glut
amine to the nutrition of clinical patients, enterally or parenterally, may
reduce morbidity. Several excellent clinical trials have been performed to
prove efficacy and feasibility of the use of glutamine supplementation in
parenteral and enteral nutrition. The increased intake of glutamine has res
ulted in lower septic morbidity in certain critically ill patient populatio
ns. This review will focus on the efficacy and the importance of glutamine
supplementation in diverse catabolic states.